Laboratorios Farmaceuticos Rovi, S.A. Receivables

The latest receivables for ROVI.MC is $160M as of June 2026. That compares with $140M in the prior-year period — up 17.6% year over year. Investors often review this figure alongside Laboratorios Farmaceuticos Rovi, S.A.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ROVI.MC's receivables moved from $140M to $160M — a 17.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Laboratorios Farmaceuticos Rovi, S.A.'s operating scale or balance-sheet position.

A receivables figure of $160M for ROVI.MC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ROVI.MC's receivables ($160M), review year-over-year change from $140M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.